262 related articles for article (PubMed ID: 22970244)
1. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
Gao P; Peterson YK; Smith RA; Smith CD
PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
[TBL] [Abstract][Full Text] [Related]
2. Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration.
Gao P; Smith CD
Mol Cancer Res; 2011 Nov; 9(11):1509-19. PubMed ID: 21896638
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
[TBL] [Abstract][Full Text] [Related]
4. Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
Beljanski V; Knaak C; Zhuang Y; Smith CD
Invest New Drugs; 2011 Dec; 29(6):1132-42. PubMed ID: 20473784
[TBL] [Abstract][Full Text] [Related]
5. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.
Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.
Adams DR; Pyne S; Pyne NJ
Cell Signal; 2020 Dec; 76():109806. PubMed ID: 33035646
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Beljanski V; Lewis CS; Smith CD
Cancer Biol Ther; 2011 Mar; 11(5):524-34. PubMed ID: 21258214
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.
French KJ; Zhuang Y; Maines LW; Gao P; Wang W; Beljanski V; Upson JJ; Green CL; Keller SN; Smith CD
J Pharmacol Exp Ther; 2010 Apr; 333(1):129-39. PubMed ID: 20061445
[TBL] [Abstract][Full Text] [Related]
9. Targeting Sphingosine Kinases for the Treatment of Cancer.
Lewis CS; Voelkel-Johnson C; Smith CD
Adv Cancer Res; 2018; 140():295-325. PubMed ID: 30060814
[TBL] [Abstract][Full Text] [Related]
10. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
Pitman MR; Powell JA; Coolen C; Moretti PA; Zebol JR; Pham DH; Finnie JW; Don AS; Ebert LM; Bonder CS; Gliddon BL; Pitson SM
Oncotarget; 2015 Mar; 6(9):7065-83. PubMed ID: 25788259
[TBL] [Abstract][Full Text] [Related]
11. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.
Watson DG; Tonelli F; Alossaimi M; Williamson L; Chan E; Gorshkova I; Berdyshev E; Bittman R; Pyne NJ; Pyne S
Cell Signal; 2013 Apr; 25(4):1011-7. PubMed ID: 23314175
[TBL] [Abstract][Full Text] [Related]
12. The cross roles of sphingosine kinase 1/2 and ceramide glucosyltransferase in cell growth and death.
Qin J; Kilkus JP; Dawson G
Biochem Biophys Res Commun; 2018 Jun; 500(3):597-602. PubMed ID: 29673590
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis.
Snider AJ; Ruiz P; Obeid LM; Oates JC
PLoS One; 2013; 8(1):e53521. PubMed ID: 23301082
[TBL] [Abstract][Full Text] [Related]
14. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart.
Vessey DA; Kelley M; Zhang J; Li L; Tao R; Karliner JS
J Biochem Mol Toxicol; 2007; 21(5):273-9. PubMed ID: 17912702
[TBL] [Abstract][Full Text] [Related]
15. A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
Beljanski V; Knaak C; Smith CD
J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity.
Leclercq TM; Moretti PA; Vadas MA; Pitson SM
J Biol Chem; 2008 Apr; 283(15):9606-14. PubMed ID: 18263879
[TBL] [Abstract][Full Text] [Related]
17. The regulation of p53, p38 MAPK, JNK and XBP-1s by sphingosine kinases in human embryonic kidney cells.
Alsanafi M; Kelly SL; McNaughton M; Merrill AH; Pyne NJ; Pyne S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158631. PubMed ID: 31954175
[TBL] [Abstract][Full Text] [Related]
18. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
Yan G; Chen S; You B; Sun J
Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
[TBL] [Abstract][Full Text] [Related]
19. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.
Paugh SW; Paugh BS; Rahmani M; Kapitonov D; Almenara JA; Kordula T; Milstien S; Adams JK; Zipkin RE; Grant S; Spiegel S
Blood; 2008 Aug; 112(4):1382-91. PubMed ID: 18511810
[TBL] [Abstract][Full Text] [Related]
20. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
